The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery
Open accessAbstract
Background: Valdecoxib and its intravenous prodrug parecoxib are reported to increase thromboembolic risk after coronary artery bypass grafting. The authors conducted a randomized trial to examine their safety and analgesic efficacy in patients recovering from major noncardiac surgical procedures. Methods: The trial was randomized and double-blind, with 10 days of treatment and 30 days of follow-up. Patients (n = 1,062) received either parenteral parecoxib for 3 days and oral valdecoxib for the rest of the treatment period or placebo medications throughout. The frequency of predefined adjudicated postrandomization adverse events, including cardiovascular thromboembolism, renal dysfunction, gastroduodenal ulceration, and wound-healing complications, was assessed in each group. Secondary efficacy endpoints included patients' pain ratings, opioid analgesic consumption (recorded as morphine equivalents), and reports of opioid-related adverse effects. Results: Predefined adjudicated adverse events had similar frequencies among patients who received parecoxib and valdecoxib (2.7%) and placebo patients (3.2%) (P = 0.58), including cardiovascular thromboembolic events (1.0% in each group; P = 1.0). Placebo patients consumed more morphine equivalents (66.2 +/- 92.4 mg) than did patients receiving parecoxib and valdecoxib (43.2 +/- 65.7 mg) (P < 0.001). Placebo patients had higher mean pain ratings on each of study days 2-10 (P < 0.01) and reported more opioid-related symptom distress on days 2-6 (P < 0.01). Conclusions: Parecoxib and valdecoxib are useful adjuncts to opioids for the treatment of postoperative pain in noncardiac surgical patients. Further study will be required to determine the safety profile of parecoxib and valdecoxib administered to patients with known atherosclerotic disease after noncardiac surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Cited by
Feldheiser, A., Aziz, O., Baldini, G., Cox, B. P. B. W., Fearon, K. C. H., Feldman, L. S., Gan, T. J., Kennedy, R. H., Ljungqvist, O., Lobo, D. N., et al. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12651 · Cited by 714
An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs
Ong, C. K. S., Lirk, P., Tan, C. H., & Seymour, R. A. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.698 · Cited by 587
Liu, S. S., & Wu, C. L. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000255040.71600.41 · Cited by 435
Essential Elements of Multimodal Analgesia in Enhanced Recovery After Surgery (ERAS) Guidelines
Beverly, A., Kaye, A. D., Ljungqvist, O., & Urman, R. D. (2017) · Anesthesiology Clinics · doi:10.1016/j.anclin.2017.01.018 · Cited by 432
Carmichael, J. C., Keller, D. S., Baldini, G., Bordeianou, L., Weiss, E., Lee, L., Boutros, M., McClane, J., Feldman, L. S., & Steele, S. R. (2017) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000883 · Cited by 403
Metadata
- Authors
- Nussmeier, N. A., Whelton, A. A., Brown, M. T., Joshi, G. P., Langford, R. M., Singla, N. K., Boye, M. E., & Verburg, K. M.
- Venue
- Anesthesiology
- Published
- 2006-03-01
- Volume
- 104
- Issue
- 3
- Pages
- 518-526
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2068398025
- Cited by
- 162
- References
- 1
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery. https://app.cochat.ai/papers/10.1097/00000542-200603000-00020
- The paper
- Nussmeier, N. A., Whelton, A. A., Brown, M. T., Joshi, G. P., Langford, R. M., Singla, N. K., Boye, M. E., & Verburg, K. M. (2006). Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery. Anesthesiology. https://doi.org/10.1097/00000542-200603000-00020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.